Removable Stents for Neonates with Cyanotic Congenital Heart Disease(CCHD)

Information

  • Research Project
  • 8653305
  • ApplicationId
    8653305
  • Core Project Number
    R43HL117338
  • Full Project Number
    6R43HL117338-02
  • Serial Number
    117338
  • FOA Number
    RFA-HD-12-192
  • Sub Project Id
  • Project Start Date
    8/1/2013 - 11 years ago
  • Project End Date
    7/31/2015 - 9 years ago
  • Program Officer Name
    KALTMAN, JONATHAN R
  • Budget Start Date
    8/1/2013 - 11 years ago
  • Budget End Date
    7/31/2015 - 9 years ago
  • Fiscal Year
    2013
  • Support Year
    02
  • Suffix
  • Award Notice Date
    8/1/2013 - 11 years ago
Organizations

Removable Stents for Neonates with Cyanotic Congenital Heart Disease(CCHD)

DESCRIPTION (provided by applicant): Current treatment of many forms of congenital heart disease requires multiple surgical procedures starting shortly after birth, with attendant high morbidity and potential mortality. A promising alternative treatment calls for placing a stent in te patent ductus arteriosus (PDA), in order to delay definitive repair until the child is older and wil have a lower risk. A novel stent specifically designed for implantation in the neonate PDA is proposed, in order to overcome the difficulties that clinicians have experienced with this new procedure in newborns, complications arising from the fact that the stents used were not designed for this purpose. An interdisciplinary team of engineers and pediatric cardiologists will (1) identify/document the requirements for a stent to be implanted in the newborn PDA, including removal; (2) perform analytical and in vitro studies with phantoms to identify the most promising candidate designs for the stent and removal instrumentation; (3) conduct an in vivo pilot study in a suitable animal model to evaluate deployment, recaptureability, trackability and radiopacity; and (4) conduct a pilot long-term animal study to assess safety and efficacy. In this latter study, proposed stent designs will be compared with stents currently being used, in regard to maintenance of patency of the PDA, tissue inflammation, and safe removal from the PDA in the presence of adherent endothelial tissue. These studies will form a compelling foundation for completing development of a PDA stent for treatment of Cyanotic Congenital Heart Disease in neonates.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    6
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    244857
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:244857\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    VIVONICS, INC.
  • Organization Department
  • Organization DUNS
    078513593
  • Organization City
    SUDBURY
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    017761142
  • Organization District
    UNITED STATES